Funded startups/Hemanext Inc.
HI

Hemanext Inc.

SEC filing
Other Health Care · Lexington, MA
Form D on EDGAR
Amount raised$20Msold at filing
Total offering$24M$4M still open
Investors in the raise29count reported to the SEC
FiledAug 5, 2025first sale Jul 18, 2025

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Robert J. HaimeExecutive Officer
Eric J. NewmanExecutive Officer
Peter A. TestaDirector
Daan M. KokExecutive Officer
Paul M. NessDirector
Geoffrey M. CrouseDirector
Andrew DunhamExecutive Officer, Director
Laura J. DanielsExecutive Officer
Eduardo Patrick AvayuDirector
Philip M. PeadDirector
Stephen A. EckertDirector
Joseph M. GroganDirector

Executive officers, directors and promoters as listed on the Form D.

Filing history

FormFiledAmount soldOffering
DAug 5, 2025$20M$24MEDGAR
DJul 31, 2025$21.7M$21.7MEDGAR